Welcome to LookChem.com Sign In|Join Free
  • or
2-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

960503-91-7

Post Buying Request

960503-91-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

960503-91-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 960503-91-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,6,0,5,0 and 3 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 960503-91:
(8*9)+(7*6)+(6*0)+(5*5)+(4*0)+(3*3)+(2*9)+(1*1)=167
167 % 10 = 7
So 960503-91-7 is a valid CAS Registry Number.

960503-91-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine

1.2 Other means of identification

Product number -
Other names 6-METHOXYPYRAZIN-2-YLBORONIC ACID PINACOL ESTER

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:960503-91-7 SDS

960503-91-7Relevant academic research and scientific papers

AMINOPYRIMIDINE DERIVATIVES AS CTPS1 INHIBITORS

-

Page/Page column 163, (2020/04/17)

Compounds of formula (I): (I) and related aspects.

HETEROCYCLIC COMPOUNDS AND USES THEREOF

-

Paragraph 0987; 0988, (2013/03/26)

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including P13 kinase activity, are described herein.

New Compounds 319

-

Page/Page column 34-35, (2008/06/13)

This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

AMINO- IMIDAZOLONES AND THEIR USE AS A MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT. ALZHEIMER DISEASE, NEURODEGENERATION AND DEMENTIA.

-

Page/Page column 88, (2008/06/13)

This invention relates to novel compounds having the structural formula I below: [Chemical formula should be inserted here. Please see paper copy] and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 960503-91-7